Skip to main content
. 2021 Mar 1;21:73. doi: 10.1186/s12890-021-01434-5

Table 1.

Patients’ demographics

Characteristic All (n = 119) Successful (n = 75) Unsuccessful (n = 44) P value
Age (year) 45 (28, 56) 43 (24, 55) 50 (34, 59) 0.034*
Female sex—no. (%) 52 (43.7) 39 (52.0) 13 (29.5) 0.017*
Smoking status 0.035*
 Current 26 (21.9) 11 (14.7) 15 (34.1)
 Former 21 (17.6) 13 (17.3) 8 (18.2)
Nonsmoker 72 (60.5) 51 (68.0) 21 (47.7)
Underlying lung disease
 COPD 8 (6.7) 6 (8.0) 2 (4.5) 0.709
 Asthma 4 (3.4) 2 (2.7) 2 (4.5) 0.626
 Lung cancer 9 (7.6) 6 (8.0) 3 (6.8) 1.000
 Bronchiectasis 3 (2.5) 3 (4.0) 0 0.295
Symptom
 Cough 51 (42.9) 36 (48.0) 15 (34.1) 0.139
 Fever 6 (5.0) 4 (5.3) 2 (4.5) 1.000
 Dyspnea 108 (90.8) 68 (90.7) 40 (90.9) 1.000
 Chest pain 4 (3.4) 1 (1.3) 3 (6.8) 0.142
WBC (× 109/l) 6.40 (5.10, 7.60) 5.90 (5.24, 7.40) 6.65 (4.68, 8.35) 0.725
Neutrophil percentage (%) 64.8 (56.6, 71.0) 64.5 (56.6, 70.0) 65.4 (56.8, 72.0) 0.928
CRP (mg/l) 2.5 (0.8, 7.8) 2 (0.6, 4.9) 5 (1.1, 10.5) 0.027*
ESR (mm/h) 14 (8, 24) 12 (7, 19) 17.5 (8, 30.8) 0.130
ABG 0.460
 Type I respiratory failure 3 (2.8) 3 (4.8) 0 (0)
 Type II respiratory failure 4 (3.7) 2 (3.2) 2 (4.5)
 CO2 retention 9 (8.4) 4 (6.3) 5 (11.4)
FEV1/pred (%) 52.9 ± 20.2 54.9 ± 20.1 48.4 ± 20.1 0.198
PEF/pred (%) 35.7 (18.6, 63.1) 39.0 (19.4, 60.7) 24.4 (15.7, 69.2) 0.494
FVC/pred (%) 79.3 ± 18.8 80.8 ± 19.2 76.0 ± 17.9 0.312
FEV1/FVC (%) 57.8 (38.4, 71.0) 60.1 (38.0, 71.0) 48.1 (39.2, 75.5) 0.666

Data were expressed as count (percentage), mean ± SD or median (interquartile range) as appropriate

COPD chronic obstructive pulmonary diseases, FEV1 forced expiratory volume in one second, PEF peak expiratory flow, FVC forced vital capacity, CRP C-reactive protein, ESR erythrocyte sedimentation rate, WBC white blood cell, CO2 Carbon dioxide, ABG arterial blood gas

*p < 0.05